ArticleMedicine2025
Development and comparison of OCT-based prediction models for diabetic retinopathy using LASSO and random forest.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic retinopathy (DR) is a leading cause of vision impairment among individuals with type 2 diabetes mellitus (T2DM). This study aimed to construct and evaluate predictive models for DR by integrating clinical data with optical coherence tomography (OCT) parameters, using both Least Absolute Shrinkage and Selection Operator (LASSO) regression and random forest (RF) algorithms. A retrospective analysis was conducted on medical records of T2DM patients admitted between September 2020 and December 2023. After applying inclusion and exclusion criteria, 10,054 cases were selected. Patients were randomly assigned to training (70%) and validation (30%) cohorts. LASSO regression was used for variable selection, followed by logistic modeling. A RF model was also developed using the same features. Model performance was assessed using receiver operating characteristic curves, and differences were analyzed via the DeLong test. Key predictors identified included gender, insulin therapy, duration of diabetes, urinary albumin-to-creatinine ratio, and retinal vessel density. The RF model demonstrated superior performance with an areas under the curve of 0.89, compared to 0.79 for the LASSO model (P < .05). Retinal vessel density was consistently a protective factor, while prolonged diabetes duration and elevated albumin-to-creatinine ratios were associated with increased DR risk. OCT-derived retinal metrics, particularly vessel density, enhance the predictive capability of DR risk models. Among the 2 approaches, the RF model exhibited better classification performance and may serve as a practical tool for early screening and individualized risk assessment in clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.